Maciej Sałaga

2.3k total citations
78 papers, 1.8k citations indexed

About

Maciej Sałaga is a scholar working on Surgery, Cellular and Molecular Neuroscience and Gastroenterology. According to data from OpenAlex, Maciej Sałaga has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 23 papers in Cellular and Molecular Neuroscience and 23 papers in Gastroenterology. Recurrent topics in Maciej Sałaga's work include Neuropeptides and Animal Physiology (22 papers), Gastrointestinal motility and disorders (19 papers) and Helicobacter pylori-related gastroenterology studies (13 papers). Maciej Sałaga is often cited by papers focused on Neuropeptides and Animal Physiology (22 papers), Gastrointestinal motility and disorders (19 papers) and Helicobacter pylori-related gastroenterology studies (13 papers). Maciej Sałaga collaborates with scholars based in Poland, Germany and United States. Maciej Sałaga's co-authors include Jakub Fichna, Marta Sobczak, Martin Storr, Hubert Zatorski, Agata Binienda, Radzisław Kordek, Marta Zielińska, Wanda M. Krajewska, Adam I. Cygankiewicz and Chunqiu Chen and has published in prestigious journals such as PLoS ONE, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Maciej Sałaga

76 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maciej Sałaga Poland	27	618	390	353	328	309	78	1.8k
Raquel Abalo Spain	30	596 1.0×	564 1.4×	276 0.8×	335 1.0×	389 1.3×	100	2.6k
Francesca Crema Italy	24	761 1.2×	472 1.2×	273 0.8×	491 1.5×	300 1.0×	71	2.3k
Zbigniew Śliwowski Poland	34	805 1.3×	536 1.4×	167 0.5×	251 0.8×	814 2.6×	88	2.9k
Robert Pajdo Poland	34	677 1.1×	583 1.5×	196 0.6×	274 0.8×	864 2.8×	90	2.9k
Carolina Pellegrini Italy	32	1.3k 2.1×	447 1.1×	160 0.5×	419 1.3×	336 1.1×	81	2.8k
Eckhard Beubler Austria	26	706 1.1×	352 0.9×	557 1.6×	441 1.3×	365 1.2×	88	2.2k
Rudolf Schicho Austria	34	972 1.6×	670 1.7×	386 1.1×	321 1.0×	554 1.8×	87	3.2k
Wiesław W. Pawlik Poland	34	516 0.8×	664 1.7×	320 0.9×	297 0.9×	1.1k 3.7×	141	3.2k
Danuta Drozdowicz Poland	36	641 1.0×	572 1.5×	273 0.8×	338 1.0×	1.2k 4.0×	112	3.2k
Carla Cirillo Belgium	27	554 0.9×	291 0.7×	187 0.5×	686 2.1×	543 1.8×	49	2.1k

Countries citing papers authored by Maciej Sałaga

Since Specialization

Citations

This map shows the geographic impact of Maciej Sałaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Sałaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Sałaga more than expected).

Fields of papers citing papers by Maciej Sałaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maciej Sałaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Sałaga. The network helps show where Maciej Sałaga may publish in the future.

Co-authorship network of co-authors of Maciej Sałaga

This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Sałaga. A scholar is included among the top collaborators of Maciej Sałaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Sałaga. Maciej Sałaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Binienda, Agata, et al.. (2025). Serotonin Receptors Polymorphisms Are Associated With Cyclic Vomiting Syndrome. Neurogastroenterology & Motility. 37(5). e15012–e15012.

Tarasiuk, Aleksandra, Gregory C. Rutledge, Krzysztof Berniak, et al.. (2024). Cholesterol Nanofiber Patches with Sustainable Oil Delivery Eliminate Inflammation in Atopic Skin. ACS Applied Materials & Interfaces. 16(29). 37783–37794. 3 indexed citations

Kordek, Radzisław, et al.. (2023). Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis. Inflammopharmacology. 32(1). 377–392. 12 indexed citations

Binienda, Agata, et al.. (2020). Dietary Carbohydrates and Lipids in the Pathogenesis of Leaky Gut Syndrome: An Overview. International Journal of Molecular Sciences. 21(21). 8368–8368. 50 indexed citations

Bartoszek, Adrian, Ee Von Moo, Agata Binienda, et al.. (2019). Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases. Pharmacological Research. 152. 104604–104604. 49 indexed citations

Sałaga, Maciej, Agata Binienda, Ritesh Tichkule, et al.. (2018). The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome. European Journal of Pharmacology. 836. 34–43. 12 indexed citations

Zielińska, Anna, Maciej Sałaga, Marcin Włodarczyk, & Jakub Fichna. (2018). Chronic abdominal pain in irritable bowel syndrome – current and future therapies. Expert Review of Clinical Pharmacology. 11(7). 729–739. 13 indexed citations

Kristinsson, Hjalti, Maciej Sałaga, Hubert Zatorski, et al.. (2017). Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner. Molecular and Cellular Endocrinology. 472. 117–125. 40 indexed citations

Binienda, Agata, Martin Storr, Jakub Fichna, & Maciej Sałaga. (2017). Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review. Current Drug Targets. 19(15). 1774–1781. 31 indexed citations

10.

Sałaga, Maciej, Anna Mokrowiecka, Marta Zielińska, et al.. (2017). New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration. Journal of Pharmacology and Experimental Therapeutics. 363(1). 92–103. 23 indexed citations

11.

Sałaga, Maciej, Martin Storr, Kirill A. Martemyanov, & Jakub Fichna. (2016). RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives. BioEssays. 38(4). 344–354. 13 indexed citations

12.

Zielińska, Marta, et al.. (2015). Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms. Pharmacological Reports. 68(1). 32–36. 11 indexed citations

13.

Sałaga, Maciej, Prabhakar R. Polepally, Marta Zielińska, et al.. (2015). Salvinorin A analogues PR‐37 and PR‐38 attenuate compound 48/80‐induced itch responses in mice. British Journal of Pharmacology. 172(17). 4331–4341. 17 indexed citations

14.

Zielińska, Marta, Gerta Cami‐Kobeci, Maciej Sałaga, et al.. (2015). Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice. European Journal of Pharmacology. 765. 582–590. 22 indexed citations

15.

Sobczak, Marta, Gerta Cami‐Kobeci, Maciej Sałaga, Stephen M. Husbands, & Jakub Fichna. (2014). Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms. European Journal of Pharmacology. 736. 63–69. 27 indexed citations

16.

Sałaga, Maciej, Prabhakar R. Polepally, Piotr K. Zakrzewski, et al.. (2014). Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors. Biochemical Pharmacology. 92(4). 618–626. 29 indexed citations

17.

Zielińska, Marta, et al.. (2014). Role of Transient Receptor Potential Channels in Intestinal Inflammation and Visceral Pain. Inflammatory Bowel Diseases. 21(2). 419–427. 38 indexed citations

18.

Sałaga, Maciej, Anna Mokrowiecka, Piotr K. Zakrzewski, et al.. (2014). Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH). Journal of Crohn s and Colitis. 8(9). 998–1009. 86 indexed citations

19.

Fichna, Jakub, JodiAnne T. Wood, Malvina Papanastasiou, et al.. (2013). Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study. PLoS ONE. 8(12). e85073–e85073. 48 indexed citations

20.

Sobczak, Marta, Anna Mokrowiecka, Adam I. Cygankiewicz, et al.. (2013). Anti-Inflammatory and Antinociceptive Action of an Orally Available Nociceptin Receptor Agonist SCH 221510 in a Mouse Model of Inflammatory Bowel Diseases. Journal of Pharmacology and Experimental Therapeutics. 348(3). 401–409. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact